| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.27B | 2.60B | 2.90B | 3.21B | 3.07B | 2.11B |
| Gross Profit | -77.09M | 34.18M | 316.20M | 793.27M | 813.18M | 34.21M |
| EBITDA | -133.72M | -36.64M | 306.48M | 813.12M | 695.48M | 147.50M |
| Net Income | -561.52M | -505.39M | -152.34M | 201.56M | 379.24M | -241.78M |
Balance Sheet | ||||||
| Total Assets | 4.86B | 5.41B | 6.27B | 5.85B | 4.04B | 2.85B |
| Cash, Cash Equivalents and Short-Term Investments | 29.04M | 8.10M | 62.93M | 224.06M | 413.26M | 14.54M |
| Total Debt | 2.81B | 3.40B | 3.69B | 3.14B | 2.56B | 2.18B |
| Total Liabilities | 4.69B | 5.05B | 5.35B | 4.79B | 3.21B | 2.83B |
| Stockholders Equity | 220.94M | 403.22M | 908.10M | 1.06B | 822.07M | 16.98M |
Cash Flow | ||||||
| Free Cash Flow | -88.34M | -111.57M | 5.69M | -58.83M | -228.16M | -52.82M |
| Operating Cash Flow | -3.55M | -103.33M | 224.47M | 715.30M | 435.30M | 6.58M |
| Investing Cash Flow | 201.89M | 280.47M | -718.51M | -1.16B | -650.26M | -57.80M |
| Financing Cash Flow | -222.68M | -232.57M | 332.57M | 272.77M | 593.86M | 55.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$4.08B | 7.18 | 9.36% | 6.07% | -3.73% | 6.09% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | HK$1.21B | 16.88 | 3.61% | 2.41% | -8.51% | -68.34% | |
57 Neutral | HK$2.78B | 3.69 | 13.87% | ― | 9.20% | 213.87% | |
54 Neutral | HK$1.22B | 18.94 | 2.46% | 3.36% | -5.29% | -32.47% | |
46 Neutral | HK$162.76M | -0.27 | -112.79% | ― | -22.72% | -212.73% | |
44 Neutral | €153.61M | -1.89 | -13.04% | ― | -17.15% | 30.94% |
Ko Yo Chemical (Group) Limited has announced updates regarding its financial strategies and operational improvements as part of its annual report. The company has been actively negotiating with banks to restructure loans, aiming for a repayment schedule of 3 to 5 years. Additionally, the company has optimized its natural gas source at the Guangan plant, reducing production costs and increasing benefits. The Dazhou plant successfully shipped its export quota of urea, boosting revenue. The company is also enhancing its sales model by increasing direct sales customers and optimizing production at its Guang’an and Jiangsu factories. These measures are expected to strengthen the company’s financial position and operational efficiency.
Ko Yo Chemical (Group) Limited has announced the composition of its board of directors and the roles within its board committees. The board includes executive directors such as Mr. Tang Guoqiang, who serves as Chairman, and Mr. Fan Chao, the Chief Executive Officer. The independent non-executive directors are Mr. Xu Congcai, Mr. Le Yiren, and Ms. Lu Yi, who also serve on various board committees. This announcement provides clarity on the governance structure of the company, potentially impacting its strategic direction and stakeholder confidence.
Ko Yo Chemical (Group) Limited announced the resignation of Mr. Shi Jianmin from his roles as Executive Director, Chief Executive Officer, and Authorised Representative, effective September 19, 2025, as he wishes to focus on personal endeavors. Mr. Fan Chao, who has been an executive director since May 2025, will assume the roles vacated by Mr. Shi. Mr. Fan brings a wealth of experience from previous roles in petrochemical process safety, investment management, and bio-pharmaceuticals, which is expected to positively impact the company’s strategic direction and operations.
Ko Yo Chemical (Group) Limited reported an unaudited loss of approximately RMB185.8 million for the first half of 2025, an increase of RMB56.1 million compared to the same period in 2024. The company’s turnover decreased by 14.1% to approximately RMB1,100 million, primarily due to lower product selling prices. The net cash outflow from operating activities was RMB32.8 million, a significant decrease from the net cash inflow of RMB62.9 million in the previous year. The board has decided not to distribute any interim dividends for this period.
Ko Yo Chemical (Group) Limited has amended and adopted the terms of reference for its Nomination Committee, which is responsible for reviewing the board’s structure, size, and composition. The committee’s duties include identifying qualified individuals for board membership, assessing the independence of directors, and making recommendations on appointments and succession planning. This move aims to ensure a transparent and fair selection process for board members, enhancing the company’s governance and aligning with its corporate strategy.